Duration = 11 Change in Daily who have had weeks Frequency of Hot a bi-lateral Follow-up = at 8 or Flashes Between oophorectomy 12 weeks Baseline and Week (surgical removal 8 as Assessed by of both ovaries). Prospective Daily without a Diaries Mean – uterus who still (95% CI) have ovaries, under certain Escitalopram: -4.60 conditions (-5.47 to -3.74) determined during Placebo: -3.20 screening to -2.24) p<0.001* Daily Severity of Hot Flashes Assessed by Prospective Daily Diaries Mean – (95% CI) Escitalopram: 2.16 (2.07 to 2.24) Placebo: 2.19 (2.10 to 2.28) Change in Daily Severity of Hot Flashes Between Baseline and Week 8 as Assessed by Prospective Daily
Duration = 11 weeks Follow-up = at 8 or 12 weeks who have had a bi-lateral oophorectomy (surgical removal of both ovaries). without a uterus who still have ovaries, under certain conditions determined during screening Change in Daily Frequency of Hot Flashes Between Baseline and Week 8 as Assessed by Prospective Daily Diaries – Mean (95% CI) Escitalopram: -4.60 (-5.47 to -3.74) Placebo: -3.20 to -2.24) p<0.001* Daily Severity of Hot Flashes Assessed by Prospective Daily Diaries – Mean (95% CI) Escitalopram: 2.16 (2.07 to 2.24) Placebo: 2.19 (2.10 to 2.28) Change in Daily Severity of Hot Flashes Between Baseline and Week 8 as Assessed by Prospective Daily